Nitric oxide: A short lived molecule stays alive

Pharmacological Research

Volumn 61, Issue 4, 2010, Pages 265-268

  Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Guanylyl cyclase; HIF 1; Lipid nitration; Mitochondria; Nitration; Nitrosation; Superoxide; Tumor

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SILDENAFIL;

CARCINOGENESIS; HOST RESISTANCE; HUMAN; LIPID OXIDATION; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VASODILATATION;

HUMANS; NEOPLASMS; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 77649337247     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.11.002     Document Type: Review

References (30)

1. Douglas D.T., Ridnour L.A., Isenberg J.S., Flores-Santana W., Switzer C.H., Donzellie S., et al. The chemical biology of nitric oxide: Implications in cellular signaling. Free Radic Biol Med 45 (2008) 18-31
2. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chadhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 4 (1987) 9265-9269
3. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
4. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
5. Kimura H., Mittal C.K., and Murad F. Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. Nature 257 (1975) 700-702
6. Bryan N.S., Bian K., and Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 14 (2009) 1-18
7. Derbyshire E.R., and Marletta M.A. Biochemistry of soluble guanylate cyclase. Handb Exp Pharmacol 191 (2009) 17-31
8. Kemp-Harper B., and Schmidt H.H. cGMP in the vasculature. Handb Exp Pharmacol 191 (2009) 447-467
9. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423 (2004) 12-22
10. Handy D.E., and Loscalzo J. Nitric Oxide and posttranslational modification of the vascular proteome. S-nitrosation of reactive thiols. Arterioscler Thromb Vasc Biol 26 (2006) 697-705
11. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2 (2005) 150-166
12. Martínez-Ruiz A., and Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 75 (2007) 220-228
13. Brüne B. Nitric oxide: NO apoptosis or turning it ON?. Cell Death Differ 8 (2003) 864-869
14. Ischiropoulos H. Protein tyrosine nitration-an update. Arch Biochem Biophys 484 (2009) 117-121
15. Peluffo G., and Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75 (2007) 291-302
16. Schildknecht S., and Ullrich V. Peroxynitrite as regulator of vascular prostanoid synthesis. Arch Biochem Biophys 484 (2009) 183-189
17. Ridnour L.A., Hussain S.P., Harris C.C., and Wink D.A. The reemergence of nitric oxide and cancer. Nitric Oxide 19 (2008) 65-67
18. Mocellin S. Nitric oxide: cancer target or anticancer agent?. Curr Cancer Drug Targets 2 (2009) 214-236
19. Sonveaux P., Jordan B.F., Gallez B., and Feron O. Nitric oxide delivery to cancer: why and how?. Eur J Cancer 8 (2009) 1352-1369
20. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24 (2009) 97-106
21. Dehne N., and Brüne B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315 (2009) 1791-1797
22. Galkin A., Higgs A., and Moncada S. Nitric oxide and hypoxia. Essays Biochem 43 (2007) 29-42
23. Brown G.C., and Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75 (2007) 283-290
24. Lefer D.J. Emerging role of nitrite in myocardial protection. Arch Pharm Res 32 (2009) 1127-1138
25. Schmidtko A., Tegeder I., and Geisslinger G. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci 32 (2009) 339-346
26. Perrotta C., De Palma C., and Clementi E. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology. Biol Chem 389 (2008) 1391-1397
27. Rudolph V., and Freeman B.A. Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res 105 (2009) 511-522
28. Trostchansky A., and Rubbo H. Nitrated fatty acids: mechanisms of formation, chemical characterization, and biological properties. Free Radic Biol Med 44 (2008) 1887-1896
29. Bloch K.D., Ichinose F., Roberts Jr. J.D., and Zapol W.M. Inhaled NO as a therapeutic agent. Cardiovasc Res 75 (2007) 339-348
30. Ghofrani H.A., and Grimminger F. Modulating cGMP to treat lung diseases. Handb Exp Pharmacol 191 (2009) 469-483